News

Decision Driver Analytics Rebranding Reflects New Capabilities

Decision Driver Analytics
Since its founding in 2006, Decision Driver Analytics (DDA) has grown beyond its original mission and today announced a rebranding that will position it as a premier provider of product life cycle value analysis and economic insight for drug and medical device developers.

“We had outgrown our original brand image as a firm focused only on health economics and outcomes research,” said DDA President and Founder Elizabeth Brooks, Ph.D. “Today we offer sponsors a comprehensive range of real-time research and analytical services starting from the moment they identify a compound until after their product is on the market.”

Decision Driver Analytics’ new messaging, “Navigating the Road Ahead,” reflects the company’s role as a guide to help sponsors navigate the inevitable twists and turns on the road to both regulatory and marketing success.

“Drug and medical device development is very complex and highly competitive,” Brooks said. “What we do is provide sponsors with real-time, real-world data and analysis to help them make high-value decisions about which courses of action to pursue. We can, for example, help sponsors examine the potential of a particular market niche to return a profit, or we can develop a predictive model that can determine an appropriate price at which to market a product or device.”

Brooks added that the company’s services directly impact the return on investment for drug and medical device developers. “We are eager for people to see how our new brand reflects the solutions we provide for our clients across all phases of development,” Brooks said.

To learn more about DDA, visit the new website at decision-driver.com or sign up for a demonstration.

About Decision Driver Analytics
Founded in 2006, Decision Driver Analytics provides a suite of services that covers the full range of health economics and outcomes research (HEOR) as well as the outreach materials needed to reach investors, health care providers, payers and the public. Utilizing veteran health economists, epidemiologists, biostatisticians, medical writers and reimbursement experts, DDA’s services include complete product life cycle value analysis, strategy and planning, clinical economic study services, predictive modeling analytics, definitive analysis studies, communication and sales training.

###